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Abstract 
Background: HoMEcare aRm rehabiLItatioN (MERLIN) is an unactuated version of the robotic device ArmAssist 
combined with a telecare platform. Stroke patients are able to train the upper limb function using serious games at 
home. The aim of this study is to investigate the effect of MERLIN training on the upper limb function of patients with 
unilateral upper limb paresis in the chronic phase of stroke (> 6 months post stroke).
Methods: Patients trained task specific serious games for three hours per week during six weeks using an unactuated 
version of a robotic device. Progress was monitored and game settings were tailored through telerehabilitation. Meas-
urements were performed six weeks pre-intervention (T0), at the start (T1), end (T2) and six weeks post-intervention 
(T3). Primary outcome was the Wolf Motor Function Test (WMFT). Secondary outcomes were other arm function tests, 
quality of life, user satisfaction and motivation.
Results: Twelve patients were included, ten completed the training. From start of the intervention to six weeks follow 
up, WMFT improved significantly with 3.8 points (p = .006), which is also clinically relevant. No significant changes in 
quality of life were observed. Patients were overall satisfied with the usability of the device. Comfort and the robust-
ness of the system need further improvements.
Conclusion: Patients in the chronic phase of stroke significantly improved their upper limb function with the MERLIN 
training at home.
Trial registration This study is registered at the Netherlands Trial Register (NL7535). Registered 18–02-2019, https ://
www.trial regis ter.nl/trial /7535.
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Background
Stroke is common in the general population, with annu-
ally 1.1 million people in Europe suffering from stroke 
[1]. After stroke, almost 77% of the patients have a paretic 
upper limb with loss of function, leading to a lower qual-
ity of life [2, 3]. During recovery, patients and therapists 
have to focus on many rehabilitation goals such as improv-
ing balance and gait, and reducing spasticity. Upper limb 
function is often undertreated according to patients, and 
consequently many return home from a hospital or reha-
bilitation center with remaining disabilities [4, 5]. It is gen-
erally believed that after six months, a plateau in functional 
motor recovery is reached [6–8]. However, more evidence 
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is emerging that patients in the chronic phase of stroke are 
able to improve the upper limb function significantly [7, 
8]. Therefore, training has to involve a few key parameters 
that are important for motor learning such as high inten-
sity training, many repetitions and a task specific approach 
[9]. However, this is not yet generally available in practice 
for patients in the chronic phase of stroke, possibly due to 
the high costs of individual sessions with a therapist. More 
affordable ways of providing intensive, task specific ther-
apy in the chronic phase of stroke are needed.
Home rehabilitation could fill the gap of insufficient 
amount of training for patients in the chronic phase of 
stroke. Using telerehabilitation (providing rehabilitation via 
online communication), the patient can train at home, and 
the therapist is able to provide assistance from a distance 
using online communication. Telerehabilitation combined 
with serious games may increase the engagement of the 
patient with the therapy [10]. Serious games are computer 
games used for training or educational purposes [11]. Keep-
ing patients motivated is of utmost importance because 
patients express that performing the same exercises may 
lead to boredom and inhibits continuation of training [5]. By 
providing various serious games with different levels of dif-
ficulty, the patient may be more motivated to continue the 
training program, which may lead to more improvement 
in arm function [12]. A positive dose–response relation 
between the amount of training and upper limb improve-
ment emphasizes the need for intensive training [13].
Serious games and telerehabilitation can be combined 
with training devices to even further increase the effec-
tiveness of therapy. Robot-assisted training devices, con-
taining an actuator or motor, have shown to be effective 
in improving the upper limb function in stroke patients 
[14]. However, these devices are often expensive and 
therefore not suitable to be used at home and supervi-
sion is needed due to safety issues. Unactuated devices 
could be a cheaper alternative, safer to use at home and 
may have the same training effect. In comparison to the 
large amount of robotic devices that are studied, only a 
few studies investigated non-robotic devices. The Ther-
apy Wilmington Robotic Exoskeleton (T-WREX) and 
its commercially available version Armeo Spring are the 
most investigated non-robotic devices that were suc-
cessful in improving the arm function [15–17]. Although 
the name of T-WREX presumes a robotic device, both 
T-WREX and Armeo Spring are passive arm orthoses 
based on springs which contain several sensors to meas-
ure movements of the arm and hand. Unfortunately, 
these devices are still expensive due to mechanical com-
plexity and too large to be used at home. According to 
therapists, costs and home use are important determi-
nants for successful rehabilitation devices [18]. The Sen-
sorimotor Active Rehabilitation Training (SMART) Arm 
is a non-robotic device which has been used at home 
during a case study to train reaching movements [19, 20]. 
Preliminary results looked promising, however the device 
is large and heavy and assistance from another person is 
needed before starting the training. It can be concluded 
that home rehabilitation with non-robotic devices is still 
in its infancy. A solution for a compact, affordable device 
that allows stroke patients to train at home is proposed.
HoMEcare aRm rehabiLItatioN (MERLIN) was 
designed to provide upper limb training at home. MER-
LIN is a combination of two existing rehabilitation solu-
tions: ArmAssist system, a robotic device based on 
serious games with visual feedback of the training (TEC-
NALIA R&I, Spain) [21, 22], and the Antari Homecare 
telerecare platform (GMV, Spain) [23]. The ArmAs-
sist system is a portable system that can measure the 
patient’s active or passive movements. A previous study 
demonstrated that deploying of the motorized version 
of the ArmAssist system early after stroke in a rehabili-
tation center was safe and more effective in comparison 
to intensive therapist-guided conventional therapy [24]. 
In the MERLIN project, the ArmAssist system was used 
in its non-motorized version, which implied that only 
the active movements of the patient were measured. The 
unactuated version of the device was selected for home 
use because it was considered safer when constant pro-
fessional supervision is not possible. In combination with 
a telecare platform, the ArmAssist system including the 
serious games seems suitable for home training.
The aim of the study was to investigate if MERLIN 
training can improve the arm function of chronic stroke 
patients during a 6-week task specific home rehabili-
tation program. We hypothesized that there will be a 
clinically relevant improvement on the WMFT after six 
weeks of MERLIN training. Gross motor movements, 
such as shoulder flexion and elbow flexion, are expected 
to improve the most after MERLIN training. The WMFT 
contains many items to test gross motor movement and 
is therefore the most suited outcome measure to answer 
this research question. Secondary aim was to investigate 
the quality of life, usability and patient motivation.
Methods
Sample size
The previous study with ArmAssist system in suba-
cute stroke showed a large effect size of 0.95 for the 
Wolf Motor Function Test (WMFT) [24]. In this study 
we included patients in the chronic phase of stroke, we 
therefore expected a medium effect size. With a power 
of 0.8, alpha of 0.05, and partial eta squared of 0.12, the 
sample size was calculated to be 12 participants for this 
repeated measures study. Including a drop-out rate of 
20%, we aimed to include 15 patients.
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Subjects
Twelve participants were enrolled in the study between 
August 2019 and January 2020 (Table  1). The inclu-
sion criteria were: 1) ≥ 18  years; 2) first incidence of a 
clinical single stroke or stuttering stroke with unilateral 
hemiparesis; 3) > 6  months and < 3  years post-stroke; 4) 
score on the Fugl-Meyer Assessment–Upper Extrem-
ity (FMA-UE) motor function of < 50; 5) able to perform 
finger extension three times and have some proximal 
voluntary movement capability in the arm; 6) ability to 
give informed consent, understand and execute sim-
ple instructions; 7) visual, mental and cognitive ability 
to assimilate and actively participate in the protocol; 8) 
being able to speak and understand Dutch or English; 
9) know how to operate a computer (or have someone 
available for assistance) and have the possibility to train 
at home (having room to set up the system and access 
to Wi-Fi). Exclusion criteria were: 1) Depression (score 
four or higher on the EuroQoL-5D (EQ-5D) depression 
item); 2) rheumatologic, orthopaedic or other neurologi-
cal disorders of the upper arm; 3) receiving occupational 
therapy or physiotherapy specifically focusing on the 
arm/hand function.
Design
A repeated measures within subject design, where the 
participant was their own control, was conducted. A con-
trol period was included in which participants did not fol-
low any functional upper limb training. This design was 
chosen to take natural recovery into account, although 
this was not expected due to the chronic phase of stroke. 
Participants were recruited via an information letter sent 
by rehabilitation physicians of two rehabilitation cent-
ers: University Medical Center Groningen (UMCG) and 
Rehabilitation Friesland, both located in the northern 
part of the Netherlands. Furthermore, informative pres-
entations were given at local stroke peer groups. Partici-
pants who showed interest in the study by returning the 
participation form, were contacted by phone to check 
the initial eligibility criteria. If patients seemed eligible, 
an intake procedure was performed at the patient’s home 
to confirm the FMA-UE and EQ-5D health state. Partici-
pants had to provide written informed consent before the 
intake procedure took place.
Intervention
According to Kwakkel et  al., the minimal training 
time needed for significant improvement of the upper 
limb function is 16  h [25], therefore participants were 
instructed to train at home for at least 18  h (16 + 10%), 
divided into three hours per week, over a course of six 
weeks. Therapy compliance was assessed by the telereha-
bilitation platform since, amongst other variables, com-
pletion of the games was registered.
Device hardware
Participants were equipped with a placemat, ArmAssist 
robotic device and a tablet (portable computer) with the 
MERLIN telerehabilitation software, which included the 
serious games. The ArmAssist (Fig. 1a) is a low-cost pas-
sive device which assesses the participant’s arm and hand 
movements and represents it on a computer screen simi-
lar to a computer mouse. The ArmAssist contains a cam-
era and encoders on the wheels to measure the absolute 
position and orientation of the device on the placemat, 
a potentiometer to measure wrist angle, a load cell to 
measure vertical force, and Force Sensing Resistor sen-
sors for measuring the grasping force. This assembly of 
sensors represents the movements in the games accord-
ingly. Different movements can be performed to interact 
with the games: moving freely in three different degrees 
over the table (horizontal, vertical and rotation), grasp-
ing/releasing, wrist rotation and isometric lifting (meas-
uring the arm weight on the device). The gravity support 
Table 1 Participant characteristics (N = 12)
COPD Chronic Obstructive Pulmonary Disease, Hem Haemorrhagic, Isch 
Ischemic, SD standard deviation
Mean ± SD
Age (Years) 64.8 ± 8.5
Gender (Male/Female) 8/4
Time since stroke (Months) 22.9 ± 9.3
Stroke type (Hem/Isch) 1/11
Side hemiparesis (Left/Right) 7/5




 Living together 1
Education
 Primary school 2
 Pre-vocational education 6
 Higher professional education 4
Work
 Did not work before stroke 1





 Diabetes Mellitus 1
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makes it easier to move the arm in space [26]. The patient 
is able to train ab-/adduction and ante-/retroflexion in 
the shoulder, elbow flexion/extension, wrist pro-/supi-
nation, mass flexion/extension of the fingers and thumb 
separately and muscle strength. A total of seven degrees 
of freedom (DoF) were available: three DoF for the posi-
tion and orientation of the device, one DoF for the lifting 
force and three DoF on the hand add-on to perform fin-
ger and thumb movements and wrist rotation. The move-
ments that were performed with the ArmAssist device 
were used to interact with the serious games that were 
visualized on the computer screen (Fig.  1b). For exam-
ple, the participant was asked to turn a card in a mem-
ory game (find two cards with the same picture) by pro-/
supinating the wrist (“Memory game”) or grasp a virtual 
written letter to complete a word that was depicted with 
missing letters (“Words game”, Fig. 1c). Another example 
is “in the bar” game, where the participant is challenged 
to pick up a virtual bottle by performing a grasping 
motion and upward lifting force. The bottle needs to be 
emptied in a glass by performing a pronation while main-
taining the grasp.
Device software
Every day, six games of five minutes each were planned 
for each participant by the researcher through the telem-
onitoring system, summing to at least 30 min of practice. 
It was advised to complete 30 min of training six days a 
week, resulting in at least three hours training per week 
as was prescribed. Participants could however adapt the 
training duration and frequency according to their pref-
erences. The therapy was task specific, repetitive, inten-
sive and randomly ordered (position of objects in the 
games was random) [9]. Feedback was provided by a 
score on the games and visual feedback provided at the 
computer screen. The therapy program was designed and 
remotely adjusted to the participants’ individual needs 
by the researcher, who had weekly consultations with 
an independent experienced occupational therapist. The 
first week of training was mainly used to familiarize the 
participant with the device using simple games. In the 
subsequent weeks the training increased in difficulty by 
adding more movements and combinations of move-
ments (e.g. grasping, lifting and moving the device). If the 
patient had trained, the therapist was able to see time of 
training, score, level, and patient’s messages.
Once every 2 weeks, the researcher visited the partici-
pants at home to recalibrate the system to the range of 
motion they were able to reach. With the calibration of 
the settings, the games continued to be challenging but 
achievable for the participant, since they were adjusted 
to 80% of the maximum range. Calibration could be per-
formed without a researcher/therapist, but to ensure that 
the calibration was performed consistently during the 
study, all calibrations were supervised by the researcher.
Outcomes
Three commonly used arm function tests were assessed 
to answer the research questions. The primary outcome 
was the WMFT to test the upper limb motor ability of 
the participant. The WMFT has two subscales: the Func-
tional Ability Scale (FAS) and the time score per item. 
The FAS is used to score the items of the WMFT on a 
6 point scale (range 0–5, maximum 75 means normal 
motor function). Maximum mean time score was 120 s, 
less time to complete the item indicated better move-
ment performance. The WMFT validity and reliability 
has been found to be excellent [27–31]. Intraclass Corre-
lation Coefficient for inter-rater and intra-rater reliability 
were 0.94 and 0.95, respectively [28]. The Minimal Clini-
cally Important Difference (MCID), a measure for small-
est change that is meaningful to the patient, is between 
3 and 6 points on the FAS and 1.5 and 2  s for the time 
domain, calculated from an anchor based and distribu-
tion based method, respectively [32].
Secondary arm function outcomes were the FMA-
UE and Action Research Arm Test (ARAT). The FMA-
UE was used to determine the motor function and 
Fig. 1  a ArmAssist device; b MERLIN system for training at home; c Example of the game “Words”
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degree of muscle synergies present. The FMA-UE con-
sists of four subscales: shoulder, wrist, hand and coor-
dination/speed. A three point scale is used to score 
movement, with a maximum of 66 points indicating a 
normal motor function of the upper limb. The inter-
nal consistency and validity are excellent [33–37]. The 
MCID is 6 to 8 points for patients in chronic phase of 
stroke [38]. The ARAT evaluates arm and hand dexter-
ity on the International Classification of Functioning, 
Disability and Health (ICF) activity level [35, 39, 40]. 
The movement is scored on a four point scale with a 
maximum of 57 points, indicating normal motor func-
tion. The MCID is 5.7 points [39]. The reliability and 
validity are excellent [29, 35–37].
The EuroQoL-5D-5L (EQ-5D) was used to determine 
the participants’ quality of life using five questions 
regarding mobility, self-care, usual activities, pain 
and anxiety/depression. The answers form a five digit 
number that represents the health state of the partici-
pants. This health state can be used to compare stroke 
patients to the norm values set for the Dutch popula-
tion [41]. The second part of the EQ-5D comprises of 
a Visual Analogue Scale (VAS). The participant rated 
their current health state from 0 (worst) to 100 (best). 
The MCID is 0.1 for the EQ-5D health state and 8.6 
points for the VAS [42]. The EQ-5D has shown reason-
able validity and acceptable responsiveness [42–44].
Lastly, questionnaires were used to investigate the 
participant’s user experience. The Intrinsic Motiva-
tion Inventory (IMI), System Usability Scale (SUS) and 
Dutch-Quebec User Evaluation of Satisfaction with 
Assistive Technology (D-QUEST). The IMI contains 
37 questions regarding interest/enjoyment, perceived 
competence, effort/importance, pressure/tension, per-
ceived choice, value/ usefulness [45]. The mean score 
was calculated per subscale, ranging between 1 and 7. 
Except for the subscale “pressure”, high scores indicate 
positive effects. For “pressure”, a low score reflects bet-
ter outcomes. Adequate reliability is reported for the 
IMI [45]. The SUS consists of ten questions about the 
perceived usability on a five-point Likert scale [46]. A 
percentage of the perceived usability was calculated, 
with 100 being completely satisfied with the usabil-
ity. If participants gave a score of 70 or more, it was 
considered that the device was acceptable to use. The 
SUS has shown to have an excellent reliability, concur-
rent validity and objective usability [47]. Lastly, the 
D-QUEST was also used to evaluate the opinion of 
the participant about the device on a five-point Lik-
ert scale [48]. The D-QUEST has shown to be valid, 
applicable and reliable as measure for user satisfaction 
regarding (medical) devices [48].
Measurements
All measurements and training sessions took place at the 
participant’s home. Two independent researchers were 
trained in performing the tests by a professional occu-
pational therapist with 12 years of experience in treating 
stroke patients. The independent researchers could not 
be blinded due to the design of the study, but they were 
blinded to the participants’ progress in the study. Par-
ticipants were assessed four times during the study (see 
Fig. 2). First, the participants were contacted by phone to 
check the inclusion and exclusion criteria. If they seemed 
to fulfil the eligibility criteria, the FMA-UE score and 
EQ-5D health state were assessed during a first visit. If 
participants were indeed eligible, the meeting would 
be continued as the first measurement (T0) and the 
WMFT and ARAT were assessed subsequently. After six 
weeks, the participants were assessed again (T1). Dur-
ing the period between T0-T1 the participants did not 
receive any arm/hand training and it was considered as 
control period. After T1, the participants trained dur-
ing six weeks with MERLIN. After these six weeks, the 
arm function tests were repeated (T2). In addition the 
IMI, SUS and D-QUEST were filled out. To determine 
the retention of the effects, the arm function tests were 
repeated six weeks after termination of the training (T3).
Statistics
Study data were collected and managed using REDCap 
(Research Electronic Data Capture) hosted at UMCG 
[49, 50]. REDCap is a secure, web-based software plat-
form designed to support data capture for research. Sta-
tistical analyses were performed in IBM SPSS Statistics 
(version 23). The data were checked for normality using 
the Shapiro–Wilk test and z-scores for skewness since 
the sample size was small. If the data was not signifi-
cantly different from the normal distribution, a repeated 
measures ANOVA was used. The level of statistical sig-
nificance was set at alpha < 0.05. If sphericity was vio-
lated, the Greenhouse–Geisser correction was applied. 
A Bonferroni correction was applied during post hoc 
testing due to multiple measurements. Alpha was set at 
(0.05/6) = 0.008. Non-parametric Friedman tests were 
used if the data seemed to be non-normally distributed. 
Effect sizes were calculated as partial eta squared (ηp2) to 
identify small(0.02), medium (0.13) or large (0.26) effect 
sizes [51]. Intention to treat was applied, missing data 
were replaced by the mean of the previous outcomes of 
that participant.
Consequences due to COVID‑19 pandemic
Due to COVID-19 pandemic, two of the T2 and seven 
of the T3 measurements were performed differently. 
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Measurement equipment was delivered at the patient’s 
home, including a laptop to set up a video connection. 
The patient performed the arm function tests with assis-
tance of a family member. Via the video connection, two 
raters observed and individually rated the movement 
and reached consensus about the scoring. Those proto-
col changes were approved by a special COVID-19 pan-
demic task force of the UMCG and were in accordance 
with the hospital and national regulations (Institutional 
Review Board, Central Committee on Research Involving 
Human Subjects (CCMO), National Institute for Public 
Health and the Environment (RIVM) and UMCG). Three 
items of the arm function tests could not be performed 
or had to be adapted. For the FMA-UE, testing reflexes 
was not possible. However it was not expected that this 
would change in patients in the chronic phase of stroke, 
therefore previous scores were used. In the WMFT, the 
item “weight to box” and “grip strength” are two separate 
items, independent of the FAS score. The item “weight to 
box” requires at least two people to assist, which was not 
feasible and therefore not assessed during online meas-
urements. The digital Biometrics E-link hand dynamom-
eter runs on specific software that was available on the 
computer of the researcher. Due to the online measure-
ment, it was not possible to use the digital dynamometer 
and was therefore replaced with an analogue handheld 
Jamar dynamometer. It has been shown that significant 
differences exist in the hand grip scores when inter-
changing the dynamometers [52]. Therefore, the data on 
hand grip strength were not reliable and not reported.
Fig. 2 Flow diagram of time points and outcomes. ARAT Action Research Arm Test, D-QUEST Dutch-Quebec User Evaluation of Satisfaction with 
Assistive Technology, EQ-5D Euro-Quality of Life -5 Dimensions, FMA-UE Fugl Meyer Assessment -Upper Extremity, IMI Intrinsic Motivation Inventory, 
SUS System Usability Scale, WMFT Wolf Motor Function Test. One of the two patients that dropped out was willing to complete the subsequent 
measurements
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Results
Two participants dropped out, one after 3.5  weeks and 
one after 5 weeks. Reasons for both drop outs were both 
due to personal reasons and related to discomfort with 
the device. Their hands were small and the hand grip 
of the device was too large, this part of the hand grip 
could not be adjusted. Therefore, they felt uncomfortable 
using the device. The participant who dropped out after 
3.5 weeks did not participate in the T2 and T3 measure-
ments, because she was too weak due to a previous ill-
ness. The participant who dropped out after 5 weeks was 
willing to continue to participate in the post measure-
ment. Participants trained on average 15.2 h (range 2.9–
32.8) over the course of six weeks. When discarding the 
drop outs, the mean training time was 17.4 h (range 5.5–
32.8). Five out of the ten participants who completed the 
training period trained more than the prescribed 18 h.
Arm/hand function outcomes and quality of life
Over the course of the study, an improvement in upper 
limb function was observed (Fig.  3). Regarding the pri-
mary outcome, repeated measures ANOVAs revealed 
significant differences between the measurements for 
WMFT FAS (F(3,33) = 7.62, p = 0.001, ηp2 = 0.41). No 
significant differences were found between the measure-
ments for WMFT time (F(3,33) = 0.50, p = 0.689). The 
post hoc analysis on the WMFT showed a significant dif-
ference for T0–T2 (5.0 points) and T1–T3 (3.8 points).
For the secondary outcomes, significant differ-
ences were found for the FMA-UE (F(3,33) = 16.51, 
p < 0.001, ηp2 = 0.6) and ARAT (F(3,33) = 4.04, p = 0.018, 
ηp2 = 0.27). No significant differences were found between 
the measurements for EQ-5D health state (F(3,33) = 0.89, 
p = 0.459) and EQ-5D-VAS (F(3,33) = 2.18, p = 0.109). 
Post hoc analyses were performed for the arm/hand out-
comes (see Appendix: Table 3). No significant differences 
were found for T0-T1 for all outcomes. In the case of the 
FMA-UE, significant differences were found for T0–T2 
(6.8 points), T0–T3 (8.4 points), T1–T2 (5.6 points) and 
T1–T3 (7.2 points), indicating that participants signifi-
cantly improved their arm function during the interven-
tion period. The subscales of the FMA-UE showed that 
shoulder, elbow, wrist and coordination improved due to 
training using MERLIN system (see Appendix). A signifi-
cant difference in the ARAT was found for T1–T2 (4.4 
points). The difference between pre-intervention and 
retention (T1–T3) was 3.7 points. Training effects were 
retained, since none of the arm function outcomes were 
significantly different between T2 and T3.
Device related outcomes
Participants were overall satisfied with the device 
(Table  2). Eleven participants completed the SUS and 
D-QUEST questionnaires. The IMI questionnaire was 
completed by ten participants, one of them was unable to 
complete it due to cognitive deficits.
Safety
No significant adverse events related to the therapy or the 
device happened during the clinical research. Reported 
adverse events were pain in the shoulder (n = 3), neck 
(n = 2) and hand (n = 1), which were already foreseen and 
notified to the participants. The hand grip was too small 
























































Fig. 3 Mean score on arm function measurements over time for the primary outcome Wolf Motor Function (a) and secondary outcomes 
Fugl-Meyer Assessment-Upper Extremity and Action Research Arm Test (b and c). ARAT Action Research Arm Test, FMA-UE  Fugl-Meyer 
Assessment-Upper Extremity, WMFT Wolf Motor Function Test. T0 = baseline, T1 = 6 weeks after baseline, pre-intervention, T2 = post-intervention, 
T3 = 6 weeks after intervention. * = p < 0.008, ** = p < 0.001. Thick black line = mean; grey striped/dotted lines: individual data. Vertical bars 
represent standard deviation, N = 12
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on the skin. The thumb support caused pain in four par-
ticipants. One serious adverse event occurred: one par-
ticipant was admitted to the hospital during the control 
period for reasons unrelated to the research activities. 
Over the course of six weeks, patients needed on average 
on five occasions assistance via a telephone call, remote 
assistance with the computer to solve problems with the 
software or a visit to solve hardware problems. In two out 
of these five occasions, the patient required an extra visit 
besides the calibration visits, due to technical problems 
with the device.
Discussion
Training with MERLIN for six weeks improved the arm 
function of patients in the chronic phase of stroke with 
lasting results six weeks after training cessation. Train-
ing at home was feasible and patients were satisfied with 
the usability of MERLIN system. The participants’ quality 
of life did not change due to the treatment. Some minor 
adverse events related to device usage were reported.
The improvements between pre-intervention and reten-
tion found in the WMFT (3.8 points; 7.7%) and FMA-UE 
(7.2 points; 19.1%) were larger than the MCIDs and there-
fore can be considered clinically meaningful. The improve-
ment on the ARAT (3.7 points; 13.2%) was less than the 
MCID which could be due to the specific fine motor func-
tions that are assessed in this test which require independ-
ent finger control. During the clinical research presented, 
mass finger and thumb flexion and extension were trained 
instead of independent finger movements, which may be 
the reason why participants did not reach clinically mean-
ingful improvements on the ARAT.
The clinical improvement that was shown in this study 
demonstrates the importance of extended rehabilitation 
therapy after the subacute phase of stroke. Patients in 
the chronic phase of stroke often do not receive much 
therapy due to limited healthcare resources. Our study 
adds to the growing body of evidence that in the chronic 
phase of stroke improvements in the upper limb are pos-
sible, as was shown in a review by Teasell et al. [7]. The 
improvement that was observed in our study could either 
be due to plasticity in the brain or due to counteracting 
learned non-use. Non-use is the behaviour of choosing to 
use compensating movements with the non-affected side. 
Since the affected arm or hand has to be used during 
training with a non-robotic device, the patient is forced 
to use the hand. This is similar as during Constrained 
Induced Movement Therapy, which has shown signifi-
cant and clinically relevant improvements compared to 
a control group [53]. It should be considered to change 
current care protocols to provide more therapy in the 
chronic phase of stroke. Rehabilitation devices such as 
MERLIN are a great asset to make this affordable since 
personnel costs can be reduced. MERLIN includes sev-
eral functionalities for rehabilitation using less complex 
technology which is more affordable in comparison to 
similar devices such as Amadeo and Tyromotion, which 
are designed for similar therapy including active or pas-
sive modes as MERLIN does.
Out of the twelve patients, seven were unable to meet 
the prescribed training time of 18 h in 6 weeks, although 
reported motivation was high. Some examples of explana-
tions were: device or software failure, not having enough 
time due to taking care of children, need for assistance 
with training. Similar findings regarding difficulties with 
completing training time were reported in the SCRIPT 
project in which patients in the chronic phase of stroke 
trained at home with the non-robotic Saebo Mobile 
Arm Support and the SCRIPT wrist and hand orthosis 
[54]. IMI subscale scores and average training time were 
even lower in comparison to the study presented in this 
manuscript. A recent review of Chen et al. (2019) regard-
ing telerehabilitation, claims that patient motivation 
for training is one of the main challenges when patients 
train unsupervised at home [55]. The advantage of home 
training is that highly motivated participants have the 
opportunity to train without time restraints, which is 
not feasible when they train with a therapist. Partici-
pants who trained 18 h or more in our study showed on 
average more improvement than participants who were 
unable to fulfil the recommended training time. This 
finding is in line with a previous review, showing that a 
dose–response relationship exists for stroke rehabilita-
tion [13]. In the study of Wolf et al. it was also shown that 
more training could lead to larger improvements in arm 
function with robotic home training [56]. In their study, 
larger clinically significant improvements in FMA-UE 
Table 2 Device related outcomes. (N = 11)
D-QUEST Dutch- Quebec User Evaluation of Satisfaction with assistive 
Technology, IMI intrinsic Motivation Inventory, SD standard deviation, 
SUS System Usability Scale, * N = 10, one participant was unable to complete this 
questionnaire
Outcome measure Mean ± SD
SUS (0–100) 77.27 ± 16.1
D-QUEST device (1–5) 3.65 ± 0.95
D-QUEST service (1–5) 4.41 ± 0.63
D-QUEST total (1–5) 3.90 ± 0.39
IMI* (1–7)
 Interest 5.5 ± 0.50
 Competence 5.4 ± 0.67
 Effort 6.0 ± 0.35
 Pressure 2.2 ± 0.55
 Perceived choice 5.6 ± 1.36
 Usefulness 6.5 ± 0.17
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and ARAT in comparison to the current study were 
found. Fifty-one patients in the subacute phase of stroke 
were asked to train at home for 120 h in eight weeks: 80 h 
with the robotic device and 40  h of functional activi-
ties. However, the results showed that patients actually 
trained 36 h with the device. While training time with the 
device was recorded, training time for functional activi-
ties was kept in a diary which is more prone to overesti-
mation. Therapy compliance was related to the patients’ 
motivation to improve the upper limb function. Reasons 
to deviate from the protocol were: lack of motivation to 
train, responsibilities to work or family or difficulties 
with using computers. Similar results related to patient 
motivation were seen in the MERLIN study. Patients who 
are less motivated or unable to train on their own may 
benefit more from face-to-face appointments. Therapists 
could therefore take into consideration if patients are 
adequately motivated and capable for home rehabilita-
tion without direct supervision. Improvements in soft-
ware such as adding a large variety in games and levels 
could improve motivation and patient engagement.
Overall usability of the MERLIN system was rated high 
(77 out of 100 on SUS). In comparison, in the SCRIPT 
project the SUS was rated with 69% [54, 57]. Accord-
ing to an elaborated analysis of the SUS by Bangor et al., 
scores above 70 are deemed good and within the range of 
acceptable devices [46]. We can therefore conclude that 
with an average score of 77, the usability of MERLIN is 
sufficient. There is however room for improvement to 
increase the usability and prevent the adverse events that 
were reported in this study. The musculoskeletal prob-
lems (pain in shoulder, neck, hand) reported are compa-
rable to other studies that reported device related adverse 
events [58, 59]. Device improvements are suggested to 
prevent these adverse events in the future, such as to 
decrease the height of the device, offer different sizes of 
the hand grip or make the handgrip more adjustable to 
customize it for each person and increase the robustness 
of the system.
The task specific approach that was used in this study is 
one of the main strengths. The ArmAssist device allows 
more movements than most training devices that only 
focus on the shoulder and elbow [60]. The games were 
entertaining and increased in difficulty which was chal-
lenging for the participants. The therapy program was 
tailored to the participants’ capabilities to challenge the 
participant as much as possible. Easy communication 
with the participants and evaluation of their progress was 
guaranteed by the telecommunication platform. Another 
strength of home rehabilitation which was shown in this 
study is the availability of therapy under different circum-
stances. This was especially shown during the COVID-19 
pandemic, participants in the study were able to continue 
training while usual care was disrupted. Home training 
could also be a solution for people that live in rural areas, 
with less resources nearby or difficulties to drive to reha-
bilitation centers.
On the other hand, some limitations need to be men-
tioned. First, the study was underpowered due to a lack 
of suitable patients and two patients that dropped out. 
Finding suitable patients appeared to be difficult. Many 
patients who showed interest to participate had a FMA-
UE score that was too high for participation. A trial 
including a larger sample size would be desirable since 
certain trends that were now observed could yield sig-
nificant differences in a larger study group. For instance 
the non-significant trend seen in the quality of life meas-
urements (measured with the EQ-5D) between T1-T2 
appeared to be larger than the MCID.
Secondly, we used a within subject design instead of 
a between subject design using a control group. A con-
trol group would have provided stronger evidence of the 
effectivity in comparison to usual care, but this was not 
feasible within the time frame of this project, leaving 
room for future research. The training time that was not 
met by more than half of the participants has been con-
sidered a limitation for the results. Nevertheless, signifi-
cant improvements in upper limb function were shown 
with less training time. Lastly, home rehabilitation in its 
optimal form should require a minimal amount of super-
vision from a therapist. Additional visits to patients were 
needed for troubleshooting mostly related to hardware 
issues, emphasizing that the robustness of the device 
needs to be improved.
When telerehabilitation with an unactuated robotic 
device can be provided at minimal costs, this may lead 
to intensifying upper limb rehabilitation in the chronic 
phase of stroke. However, many questions regarding 
home training with (non-)robotic devices are still to be 
answered. Future research could investigate which under-
lying factors contribute to not completing the requested 
amount of training time, since this seems to be a reoccur-
ring problem in telerehabilitation studies.
Conclusion
With the MERLIN system, telerehabilitation based on 
serious games combined with an unactuated robotic 
training device, improved upper limb function in patients 
in the chronic phase of stroke in a clinically meaningful 
way. The usability of MERLIN was acceptable and most 
patients were motivated to train. In contrast to arm func-
tion, training did not have an effect on quality of life. 
Telerehabilitation based on serious games with a non-
robotic device at home seems to be effective for highly 
motivated, moderately affected chronic stroke patients.




ARAT : Action Research Arm Test; CCMO: Centrale Commissie Mensgebonden 
Onderzoek; COPD: Chronic Obstructive Pulmonary Disease; D-QUEST: 
Dutch- Quebec User Evaluation of Satisfaction with assistive Technology; DoF: 
Degrees of Freedom; EQ-5D: Euro-Quality of Life -5 Dimensions; FAS: Func-
tional Ability Scale; FMA-UE: Fugl Meyer Assessment-Upper Extremity; Hem: 
Hemorrhagic; IMI: Intrinsic Motivation Inventory; Isch: Ischemic; MCID: Minimal 
Clinically Important Difference; MERLIN: HoMEcare aRm rehabiLItatioN; RIVM: 
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Table 3 Overview of arm function and quality of life test results using intention to treat analysis (N = 12)
Repeated measures ANOVA with post hoc analysis. Only significant differences are shown, significant difference = p < 0.008
ARAT Action Research Arm Test, EQ-5D EurQoL–5 Dimensions, FAS Functional Ability Scale, FMA-UE Fugl-Meyer Assessment-Upper Extremity, SD standard deviation, 
VAS Visual Analogue Scale, WMFT Wolf Motor Function Test
Outcome measures Mean ± SD Post hoc analysis
T0 T1 T2 T3 p-value
WMFT FAS 48.00 ± 10.41 49.58 ± 11.95 52.96 ± 12.24 53.38 ± 14.08 T0–T2 = 0.003
T1–T3 = 0.006
WMFT time 23.65 ± 23.91 24.27 ± 24.97 21.86 ± 19.74 24.24 ± 24.89
FMA-UE total 36.33 ± 7.83 37.58 ± 9.38 43.17 ± 11.20 44.75 ± 11.33 T0–T2 = 0.004
T0–T3 =  < 0.001
T1–T2 = 0.003
T1–T3 =  < 0.001
FMA-UE Shoulder 21.5 ± 3.92 21.92 ± 4.27 24.92 ± 5.74 25.92 ± 5.47 T0–T3 = 0.002
T1–T2 = 0.005
T1–T3 =  < 0.001
FMA-UE Wrist 5.67 ± 2.93 5.0 ± 2.30 5.46 ± 2.57 6.04 ± 2.72 T1–T3 = 0.004
FMA-UE Hand 6.17 ± 3.27 7.17 ± 3.88 8.38 ± 4.27 8.21 ± 4.35 T0–T2 = 0.003
FMA-UE Coordination/speed 3.0 ± 1.41 3.5 ± 1.24 4.42 ± 1.16 4.58 ± 1.16 T0–T2 = 0.003
T0–T3 = 0.003
T1–T3 = 0.005
ARAT 27.33 ± 13.47 27.83 ± 15.03 32.25 ± 17.09 31.50 ± 17.68 T1–T2 = 0.007
EQ-5D health state 0.70 ± 0.13 0.73 ± 0.13 0.76 ± 0.08 0.74 ± 0.10
EQ-5D VAS 73.75 ± 18.23 70.08 ± 17.27 79.75 ± 16.23 73.92 ± 15.97
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